31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2012
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Amyloid-beta Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
- 2011
-
Mark
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
(
- Contribution to journal › Article
- 2010
-
Mark
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Cystatin C Levels are Positively Correlated with both A beta(42) and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
(
- Contribution to journal › Article
- 2009
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides
(
- Contribution to journal › Article
- 2007
-
Mark
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »